AAPLLoadingMSFTLoadingNVDALoadingGOOGLLoadingAMZNLoadingMETALoadingTSLALoadingAMDLoadingNFLXLoadingCOINLoadingPYPLLoadingSPYLoadingQQQLoadingIWMLoadingJPMLoadingVLoadingDISLoadingKOLoadingJNJLoadingNKELoadingXOMLoadingASMLLoading
FreeNVDA3 min read

One company's margin is several companies' capex

The shares last traded at 221.49, -1.80% on the session. I write mostly about the companies doing the spending. This is the company receiving a large share of it, and the two stories are the same story told from opposite ends.

NVDA
Delayed

The identity worth keeping in view

Every dollar of this company's data centre revenue is a dollar of somebody's capital spending. The customers are few, very large, and spending at a pace their own shareholders keep asking about. The supplier's margin is the customers' cost.

That does not make the revenue fragile. It makes it dependent on decisions that a small number of boards take each year, and those decisions have a history of moving together.

What I watch

  • Capital spending guidance from the largest cloud companies, which is this company's order book in all but name
  • Customer concentration, since a handful of buyers accounts for a large share of demand
  • Customers designing their own chips, which caps pricing power at the margin even where it does not replace the product
  • Gross margin, which says whether demand is still outrunning supply or supply has caught up

In a capital spending cycle, the supplier's best quarter usually sits close to the customer's most generous budget.

Why I am flat

The business is extraordinary and the demand is real. What I cannot do is forecast the spending decisions of a few customers with enough confidence to hold a view on the supplier. If I am going to be wrong about capex, I would rather be wrong about a company that can absorb it than one that depends on it.

What would change my mind

Capex guidance from the largest buyers rising while this company's margin holds. That would say demand is still ahead of supply, and that the digestion period everyone keeps predicting is still some way off.

The author holds no position in the instruments discussed. Opinion. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Past performance is not a reliable indicator of future results.

Comments

0 comments
Sign in to comment.

No comments yet

Be the first to weigh in.